Cargando…

A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction

INTRODUCTION: Alzheimer’s disease (AD) is a progressive and irreversible brain degenerative disorder early. Among all diagnostic strategies, hippocampal atrophy is considered a promising diagnostic method. In order to proactively detect patients with early Alzheimer’s disease, we built an Alzheimer’...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Kun, Piao, Sirong, Liu, Xiao, Luo, Xiao, Chen, Hongyi, Xiang, Rui, Geng, Daoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884698/
https://www.ncbi.nlm.nih.gov/pubmed/36726800
http://dx.doi.org/10.3389/fnagi.2022.1073909
_version_ 1784879775306743808
author Zhou, Kun
Piao, Sirong
Liu, Xiao
Luo, Xiao
Chen, Hongyi
Xiang, Rui
Geng, Daoying
author_facet Zhou, Kun
Piao, Sirong
Liu, Xiao
Luo, Xiao
Chen, Hongyi
Xiang, Rui
Geng, Daoying
author_sort Zhou, Kun
collection PubMed
description INTRODUCTION: Alzheimer’s disease (AD) is a progressive and irreversible brain degenerative disorder early. Among all diagnostic strategies, hippocampal atrophy is considered a promising diagnostic method. In order to proactively detect patients with early Alzheimer’s disease, we built an Alzheimer’s segmentation and classification (AL-SCF) pipeline based on machine learning. METHODS: In our study, we collected coronal T1 weighted images that include 187 patients with AD and 230 normal controls (NCs). Our pipeline began with the segmentation of the hippocampus by using a modified U2-net. Subsequently, we extracted 851 radiomics features and selected 37 features most relevant to AD by the Hierarchical clustering method and Least Absolute Shrinkage and Selection Operator (LASSO) algorithm. At last, four classifiers were implemented to distinguish AD from NCs, and the performance of the models was evaluated by accuracy, specificity, sensitivity, and area under the curve. RESULTS: Our proposed pipeline showed excellent discriminative performance of classification with AD vs NC in the training set (AUC=0.97, 95% CI: (0.96-0.98)). The model was also verified in the validation set with Dice=0.93 for segmentation and accuracy=0.95 for classification. DISCUSSION: The AL-SCF pipeline can automate the process from segmentation to classification, which may assist doctors with AD diagnosis and develop individualized medical plans for AD in clinical practice.
format Online
Article
Text
id pubmed-9884698
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98846982023-01-31 A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction Zhou, Kun Piao, Sirong Liu, Xiao Luo, Xiao Chen, Hongyi Xiang, Rui Geng, Daoying Front Aging Neurosci Aging Neuroscience INTRODUCTION: Alzheimer’s disease (AD) is a progressive and irreversible brain degenerative disorder early. Among all diagnostic strategies, hippocampal atrophy is considered a promising diagnostic method. In order to proactively detect patients with early Alzheimer’s disease, we built an Alzheimer’s segmentation and classification (AL-SCF) pipeline based on machine learning. METHODS: In our study, we collected coronal T1 weighted images that include 187 patients with AD and 230 normal controls (NCs). Our pipeline began with the segmentation of the hippocampus by using a modified U2-net. Subsequently, we extracted 851 radiomics features and selected 37 features most relevant to AD by the Hierarchical clustering method and Least Absolute Shrinkage and Selection Operator (LASSO) algorithm. At last, four classifiers were implemented to distinguish AD from NCs, and the performance of the models was evaluated by accuracy, specificity, sensitivity, and area under the curve. RESULTS: Our proposed pipeline showed excellent discriminative performance of classification with AD vs NC in the training set (AUC=0.97, 95% CI: (0.96-0.98)). The model was also verified in the validation set with Dice=0.93 for segmentation and accuracy=0.95 for classification. DISCUSSION: The AL-SCF pipeline can automate the process from segmentation to classification, which may assist doctors with AD diagnosis and develop individualized medical plans for AD in clinical practice. Frontiers Media S.A. 2023-01-16 /pmc/articles/PMC9884698/ /pubmed/36726800 http://dx.doi.org/10.3389/fnagi.2022.1073909 Text en Copyright © 2023 Zhou, Piao, Liu, Luo, Chen, Xiang and Geng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Aging Neuroscience
Zhou, Kun
Piao, Sirong
Liu, Xiao
Luo, Xiao
Chen, Hongyi
Xiang, Rui
Geng, Daoying
A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction
title A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction
title_full A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction
title_fullStr A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction
title_full_unstemmed A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction
title_short A novel cascade machine learning pipeline for Alzheimer’s disease identification and prediction
title_sort novel cascade machine learning pipeline for alzheimer’s disease identification and prediction
topic Aging Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884698/
https://www.ncbi.nlm.nih.gov/pubmed/36726800
http://dx.doi.org/10.3389/fnagi.2022.1073909
work_keys_str_mv AT zhoukun anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT piaosirong anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT liuxiao anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT luoxiao anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT chenhongyi anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT xiangrui anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT gengdaoying anovelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT zhoukun novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT piaosirong novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT liuxiao novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT luoxiao novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT chenhongyi novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT xiangrui novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction
AT gengdaoying novelcascademachinelearningpipelineforalzheimersdiseaseidentificationandprediction